The Life Sciences Speaker Series focuses on legal issues for life sciences, health care, medical device and pharmaceutical companies. Please join us for the next session of our series, "Life Sciences IPOs: How Not to Miss the Open Window – Current Issues and Best Practices."
The life sciences IPO window opened wide in early 2013, and the opportunities presented by the IPO process continue unabated in 2014. Should you consider an IPO as part of your company’s finance strategy? What are the benefits and costs of going the IPO route compared to other financing vehicles? Can your company take advantage of the open window, and if so, what issues should you consider when making that decision?
Please join Brian Korn and Steven R. London, attorneys in Pepper’s Life Sciences Practice, for an interactive discussion on IPO preparation, bridge/cross-over funding, best practices for governance and disclosure, confidential filing, testing-the-waters and other “gifts” from the JOBS Act, among other timely topics.
Don’t miss this chance to learn more about the IPO climate for life sciences companies, and how to weigh the risks and benefits of an IPO for your company.
Boston Marriott Cambridge
Two Cambridge Center, 50 Broadway
Cambridge, MA 02142
There is no fee to attend this seminar.
For more information please contact Kim MacAlister at firstname.lastname@example.org or 215.981.4249.